Data is not available at this time.
Givaudan SA is a global leader in the specialty chemicals industry, specializing in fragrance, beauty, taste, and wellbeing products. The company operates through two core divisions: Fragrance & Beauty, which offers fine fragrances, consumer products, and active beauty ingredients, and Taste & Wellbeing, which provides solutions for beverages, dairy, snacks, savory, and confectionery products. Serving consumer goods manufacturers worldwide, Givaudan leverages its deep expertise in scent and flavor innovation to maintain a dominant position in its niche. The company’s market leadership is reinforced by its extensive R&D capabilities, long-standing client relationships, and a diversified geographic footprint spanning Europe, North America, Latin America, and Asia Pacific. Givaudan’s business model thrives on recurring demand from the fast-moving consumer goods sector, where its proprietary formulations and tailored solutions create high switching costs for customers. Its focus on sustainability and natural ingredients aligns with evolving consumer preferences, further strengthening its competitive edge in the flavors and fragrances market.
Givaudan reported revenue of CHF 7.41 billion for the fiscal year, with net income reaching CHF 1.09 billion, reflecting a robust margin profile. The company’s diluted EPS stood at CHF 117.71, supported by disciplined cost management and operational efficiency. Operating cash flow was strong at CHF 1.63 billion, though capital expenditures of CHF 236 million indicate ongoing investments in innovation and capacity expansion.
The company demonstrates consistent earnings power, driven by its high-margin specialty chemicals portfolio and recurring revenue streams from global FMCG clients. Capital efficiency is evident in its ability to generate substantial operating cash flow relative to its asset base, though its debt load of CHF 4.75 billion suggests moderate leverage. Givaudan’s R&D investments underscore its commitment to maintaining technological leadership.
Givaudan maintains a solid balance sheet with CHF 749 million in cash and equivalents, providing liquidity against its total debt of CHF 4.75 billion. The company’s financial health is stable, supported by strong cash generation, though its leverage ratio warrants monitoring given cyclical exposure to consumer markets. Its ability to service debt remains secure given predictable cash flows.
Growth is underpinned by innovation in natural ingredients and expansion in emerging markets. The company’s dividend policy is shareholder-friendly, with a dividend per share of CHF 70, reflecting a commitment to returning capital while retaining flexibility for strategic investments. Long-term trends in health-conscious and sustainable products present additional growth opportunities.
With a market capitalization of CHF 30.35 billion and a beta of 0.539, Givaudan is perceived as a stable, low-volatility investment. The valuation reflects its premium positioning in the flavors and fragrances market, with investors likely pricing in steady growth and resilient demand from the consumer goods sector.
Givaudan’s strategic advantages include its R&D prowess, global distribution network, and strong client relationships. The outlook remains positive, supported by trends in natural and sustainable product demand, though macroeconomic pressures on consumer spending could pose near-term risks. The company’s focus on innovation and operational efficiency positions it well for long-term value creation.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |